We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page.
Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site.
Observe Medical ASA, 28 February 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 24 January 2020 regarding the exercise of employee share options and issue of 275,000 new shares in the Company. The NOK 71,500 share capital increase pertaining to the exercise of the employee share options…
Read moreOslo, 25 February 2020 – Observe Medical ASA (OSE: OBSERV) continued implementation of its growth strategy in the fourth quarter of 2019, including the commercialization of its first product Sippi®. “In the fourth quarter of 2019, we have taken important steps in the commercialization of Sippi. In parallel we have strengthened our foundation for value…
Read more(Oslo, 24 January 2020) Exercise of employee share options In connection with the expiry date at 24 January three employees in Navamedic ASA have exercised a total of 275,000 options in Observe Medical ASA. Employees in Navamedic ASA were granted options in Observe Medical ASA in connection with the demerger of Navamedic ASA’s Medtech division…
Read moreCarve-out financial statements full year 2016-2018 Observe Medical Group
Annual Report
Quarterly Presentation – Q1
Annual General Meeting
Half-yearly Report
Quarterly Presentation – Q3
Last updated 19 february 2020
| Name | Number of shares | % of top 20 | % of total | Country | |
|---|---|---|---|---|---|
| 1 | NAVAMEDIC ASA | 3 200 000 | 24,86% | 20,86% | Norway |
| 2 | INGERØ REITEN INV. COMPANY AS | 2 916 667 | 22,66% | 19,01% | Norway |
| 3 | UBS SWITZERLAND AG | 1 420 522 | 11,04% | 9,26% | Switzerland |
| 4 | RO, LARS | 1 320 231 | 10,26% | 8,60% | Norway |
| 5 | ALPINE CAPITAL AS | 655 964 | 5,10% | 4,28% | Norway |
| 6 | ARTAL AS | 489 341 | 3,80% | 3,19% | Norway |
| 7 | SOLEGLAD INVEST AS ¹ | 416 668 | 3,24% | 2,72% | Norway |
| 8 | LEIKERANE AS ² | 416 666 | 3,24% | 2,72% | Norway |
| 8 | TRANBERGKOLLEN INVEST AS ³ | 416 666 | 3,24% | 2,72% | Norway |
| 10 | LAPAS AS | 266 000 | 2,07% | 1,73% | Norway |
| 11 | LID, OLAV TARJEI HIORTH | 250 000 | 1,94% | 1,63% | Norway |
| 12 | KRAEBER VERWALTUNG GMBH | 214 850 | 1,67% | 1,40% | Germany |
| 13 | BUKKEVIK INVESTERING AS | 199 898 | 1,55% | 1,30% | Norway |
| 14 | ANDREASSEN, KATHRINE E. GAMBORG ¹ | 125 000 | 0,97% | 0,81% | Norway |
| 15 | NOBELSYSTEM SCANDINAVIA AS | 124 333 | 0,97% | 0,81% | Norway |
| 16 | HARDING INVEST AS | 101 438 | 0,79% | 0,66% | Norway |
| 17 | MP PENSJON PK | 100 025 | 0,78% | 0,65% | Norway |
| 18 | EILERAAS, KARL ANSKAR | 86 491 | 0,67% | 0,56% | Norway |
| 19 | BRATVEDT, ASTRID J. TORGERSEN ³ | 77 000 | 0,60% | 0,50% | Norway |
| 20 | ERIKSEN, OLE HENRIK ² | 75 000 | 0,58% | 0,50% | Norway |
| Total numer owned by top 20 | 12 872 760 | 100,00% | 83,90% | ||
| Total number of shares | 15 342 673 |
¹) Soleglad Invest AS is owned 100% of Kathrine E. Gamborg Andreassen
²) Leikerane AS is owned 100% of Ole Henrik Eriksen
³) Tranbergkollen Invest AS is owned 100% of Astrid J. Torgersen Bratvedt
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Oslo Axess
OBSERV
4 November 2019
Healthcare
NOK
NO0010865009
15 342 673
NOK 0.26
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
Observe Medical ASA per 21 january 2020
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bernt Olav Røttingsnes (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com